ArticleCardio-oncology (London, England)2025

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis.

Christopher W Hoeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.